Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections
1 other identifier
observational
280
1 country
1
Brief Summary
To examine the effect of Point-of-Care Ultrasound (POCUS) management guidance on pediatric skin and soft tissue infections treatment failure rate, as well as emergency department process outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 26, 2014
CompletedFirst Posted
Study publicly available on registry
March 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedOctober 4, 2024
September 1, 2016
1.5 years
March 26, 2014
October 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
treatment failure rate
unscheduled return visits need for subsequent procedural intervention need for subsequent admission change in therapy
7-10days
Secondary Outcomes (1)
emergency department process outcome
7-10days
Study Arms (2)
Ultrasound
those who received point-of-care ultrasound as part of their emergency department evaluation/ treatment for suspected soft tissue infections
No Ultrasound
those who did not receive point-of-care ultrasound as part of their emergency department evaluation/ treatment for suspected soft tissue infections
Eligibility Criteria
children presenting to participating pediatric emergency departments
You may qualify if:
- history and examination findings consistent with possible abscess or cellulitis per the treating clinician.
You may not qualify if:
- suspected soft tissue infections involving or near mucosal membranes (e.g. perirectal, peritonsillar, vulvovaginal areas)
- facial lesions
- paronychia or felon
- parent or patient refusal of consent
- unsuitable subjects deemed by treating clinicians.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wake Forest University Health Scienceslead
- American College of Emergency Physicianscollaborator
- Newark Beth Israel Medical Centercollaborator
- Baylor College of Medicinecollaborator
- UCSF Benioff Children's Hospital Oaklandcollaborator
- Maimonides Medical Centercollaborator
- Montefiore Medical Centercollaborator
Study Sites (1)
Advocate Christ Medical Center
Oak Lawn, Illinois, 60453, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel Lam, MD
advocate christ medical center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2014
First Posted
March 28, 2014
Study Start
March 1, 2014
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
October 4, 2024
Record last verified: 2016-09